Therese M. Hennig

Therese Hennig practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Therese Hennig's NPI, 1285718346, was assigned on October 25, 2006. Therese Hennig holds North Carolina license 103133.

Therese Hennig's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Therese Hennig's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Therese Hennig to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Therese Hennig practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Therese Hennig's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Therese Hennig is licensed in North Carolina.

CMS data shows 70 Medicare services from Therese Hennig across 3 procedure codes in 2024, for 46 Medicare patients. Medicare paid $3,290 for them. Every service was in an office.

CMS counts 46 Medicare patients who saw Therese Hennig in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high blood pressure, and 65% have high cholesterol. Their average risk score is 3.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Therese Hennig's median patient age at 73, with 43% women.

In 2024, Therese Hennig wrote 165 Medicare Part D claims for 31 patients. 85% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $307 in total drug cost. In 2023, CMS named 88 claims across 4 drugs.

Therese Hennig accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Therese Hennig as offering telehealth.

CMS Open Payments shows 8 general payments to Therese Hennig from 5 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 60% of the total. INSYS Therapeutics Inc paid the most, $4,525.